ライフサイエンスコーパス: cystoid macular edema

1 xime as measured by the incidence of POE and cystoid macular edema.

2 xel may cause ocular adverse effects such as cystoid macular edema.

3 n the central macula with or without typical cystoid macular edema.

4 1 day of treatment, and 1 patient developed cystoid macular edema.

5 ery-associated retinal complications such as cystoid macular edema.

6 s whether NSAIDS can reduce the incidence of cystoid macular edema.

7 ement of both postoperative inflammation and cystoid macular edema.

8 lar hole, diabetic retinopathy, uveitis, and cystoid macular edema.

9 can lead to retinal disease de novo, such as cystoid macular edema.

10 seudotumor cerebri, thyroid orbitopathy, and cystoid macular edema.

11 eitis-glaucoma-hyphema syndrome, and chronic cystoid macular edema.

12 ases, suboptimal visual results secondary to cystoid macular edema.

13 al anterior synechiae, or known or suspected cystoid macular edema.

14 g anterior chamber reactions, and inhibiting cystoid macular edema.

15 [4%]), retained cortical fragment (1 [4%]), cystoid macular edema (2 [8%]), and IOL subluxation (3 [

16 Cystoid macular edema after cataract surgery has a tende

17 st 1, 2001 and July 31, 2002 on the topic of cystoid macular edema after cataract surgery.

18 Twenty-seven eyes had cystoid macular edema, and 10 eyes had diffuse macular e

19 corneal edema, intraocular pressure spikes, cystoid macular edema, and posterior capsule opacificati

20 ch may include pseudocysts, macular schisis, cystoid macular edema, and subretinal fluid.

21 eyes and seven eyes with retinal pathology (cystoid macular edema, central serous retinopathy, vitre

22 complications were uveal effusion (9.3%) and cystoid macular edema (CME) (7.0%).

23 total images were acquired and evaluated for cystoid macular edema (CME) and persistence of inner ret

24 ibizumab-treated CRVO patients with resolved cystoid macular edema (CME) at month 3, those with persi

25 s pigmentosa; 37 (21%) of these patients had cystoid macular edema (CME) by OCT.

26 Published reports of the occurrence of cystoid macular edema (CME) in eyes being treated with l

27 IDs) are effective in decreasing the risk of cystoid macular edema (CME) in high-risk eyes, but must

28 Cystoid macular edema (CME) in retinitis pigmentosa (RP)

29 Current treatments for cystoid macular edema (CME) in retinitis pigmentosa (RP)

30 Cystoid macular edema (CME) is a common problem after ca

31 Cystoid macular edema (CME) occurred in 5 eyes (0.87%):

32 ld, with a vitreous haze score of >/=1.5+ or cystoid macular edema (CME) of >300 mum were enrolled.

33 ) in cataract surgery with specific focus on cystoid macular edema (CME) on the basis of expert opini

34 sual acuity, intraocular pressure (IOP), and cystoid macular edema (CME) were recorded at each visit.

35 al acuity (VA), complications, resolution of cystoid macular edema (CME), and anterior chamber and vi

36 inal hard exudates, retinal detachment (RD), cystoid macular edema (CME), and epiretinal membrane (ER

37 ourse can be complicated by inflammation and cystoid macular edema (CME), and in uveitic patients, in

38 in retinal dystrophy, differentiate it from cystoid macular edema (CME), and review the role of carb

39 ntour, persistent fetal foveal architecture, cystoid macular edema (CME), intraretinal exudates and s

40 ase, vitreous opacities, retinal detachment, cystoid macular edema (CME), macular scarring, macular h

41 uthors retrospectively selected visits where cystoid macular edema (CME), subretinal fluid (SRF), or

42 with visual acuity (VA) in eyes with uveitic cystoid macular edema (CME).

43 ntraocular pressure (IOP) increase (n = 12), cystoid macular edema (CME; n = 3), and nonarteritic ant

44 Study [ETDRS] of 55 letters or better); (2) cystoid macular edema (CMO), foveal thickness, and macul

45 The rate of cystoid macular edema decreased from 22.7% at baseline t

46 multiple processes, including postoperative cystoid macular edema, epiretinal membrane formation, ma

47 Anterior uveitis, cataract, vitritis, cystoid macular edema, epiretinal membrane, and disc ede

48 ave been shown to be effective in preventing cystoid macular edema following cataract surgery or trea

49 idence interval {CI}, 2.15-4.35], P < .001), cystoid macular edema (HR = 2.87 [95% CI, 1.41-5.82], P

50 Other complications included cystoid macular edema in 1 eye (2.4%), posterior synechi

51 t underlying pathophysiologic foundation for cystoid macular edema in retinal vascular diseases.

52 Cystoid macular edema in retinal vein occlusion occurred

53 form changes that were hyperautofluorescent, cystoid macular edema in the inner nuclear layer, no lig

54 Pseudophakic cystoid macular edema is an important cause of visual de

55 Pseudophakic cystoid macular edema is common after phacoemulsificatio

56 Usually vision loss from cystoid macular edema is temporary and responds to treat

57 1), retinal neovascularization (n = 1), and cystoid macular edema (n = 1).

58 Cystoid macular edema observed on SD OCT in very preterm

59 nd optical coherence tomography (OCT) showed cystoid macular edema on both eyes.

60 edema following cataract surgery or treating cystoid macular edema once it occurs.

61 subclinical susceptibility to postoperative cystoid macular edema or exacerbation of choroidal neova

62 Diagnosis of cystoid macular edema or new-onset macular edema in pati

63 ewed OCT scans to determine the type of DME, cystoid macular edema, or diffuse macular edema (absence

64 y related to visual acuity, age, presence of cystoid macular edema, or subjects' stress or anxiety le

65 no differences between groups when assessing cystoid macular edema (P = .96), retinal detachment (P =

66 (P = 0.15), retinal detachments (P = 0.76), cystoid macular edema (P = 0.83), or timing of complicat

67 Pseudophakic cystoid macular edema (PCME) is a common cause of visual

68 ification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, random

69 Cystoid macular edema persisted in 9 of 11 eyes affected

70 ressure control, worsening of visual acuity, cystoid macular edema, retroprosthetic membrane formatio

71 Cystoid macular edema seems to be a marker for poorer vi

72 ly [P = .001]), whereas an increased risk of cystoid macular edema was not identified for those who r

73 In one eye, development of cystoid macular edema was observed before the outer reti

74 No cystoid macular edema was observed in the control group.

75 Cystoid macular edema was present in 9, 1, 5, 9, and 1 p

76 Cystoid macular edema was seen in 25 of the 46 patients

77 as assessed by multiadjusted odds of retinal cystoid macular edema, was not increased for patients re

78 Cystoid macular edema, which was present in 40 eyes at b

79 20/13 to 20/40(+2), except in 1 patient with cystoid macular edema whose vision was 20/60(-) and 20/7

80 vascular plexus were analyzed in relation to cystoid macular edema with retention of depth informatio

81 acy (for both postoperative inflammation and cystoid macular edema) without the typically corticoster